Patents by Inventor Christopher D. Breder

Christopher D. Breder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT OF DEPRESSION
    Publication number: 20120115871
    Abstract: The invention comprises a method of treatment of depression or depression-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Application
    Filed: April 29, 2010
    Publication date: May 10, 2012
    Inventor: Christopher D. Breder
  • Pharmaceutical combinations of oxycodone and naloxone
    Patent number: 7943173
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising from 10 to 40 mg of oxycodone or a pharmaceutically acceptable salt thereof and 0.65 to 0.90 mg naloxone or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: May 17, 2011
    Assignee: Purdue Pharma L.P.
    Inventors: Christopher D. Breder, Robert D. Colucci, Stephen A Howard, Benjamin Oshlack, Curtis Wright
  • Method of treatment of aggression
    Publication number: 20100173907
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Application
    Filed: December 18, 2009
    Publication date: July 8, 2010
    Inventor: Christopher D. Breder
  • Method of treatment of attention deficit/hyperactivity disorder (ADHD)
    Publication number: 20100069390
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Application
    Filed: September 4, 2009
    Publication date: March 18, 2010
    Inventor: Christopher D. Breder
  • Pharmaceutical combinations of oxycodone and naloxone
    Publication number: 20030069263
    Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising from 10 to 40 mg of oxycodone or a pharmaceutically acceptable salt thereof and 0.65 to 0.90 mg naloxone or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 18, 2002
    Publication date: April 10, 2003
    Inventors: Christopher D. Breder, Robert D. Colucci, Stephen A. Howard, Benjamin Oshlack, Curtis Wright